DXCM · 8-K · 20261029PR000193
Share Repurchase Program
DEXCOM INC · 2026-10-29 · Importance 64 · Surprise 42 · In source text
Dexcom authorized repurchases of up to $1.0 billion of its shares in conjunction with its third-quarter 2026 results. The authorization establishes a maximum repurchase amount; the release does not state a purchase schedule or completion timeframe. Treasury stock was $3.1334 billion at September 30, 2026, compared with $2.0848 billion at December 31, 2025.
Key facts
- Dexcom announced a share repurchase authorization of up to $1.0 billion in conjunction with its Q3 results. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| cash | negative | committed | — | Dexcom announced a share repurchase authorization of up to $1.0 billion in conjunction with its Q3 results. |